医学
利拉鲁肽
危险系数
2型糖尿病
内科学
糖尿病
随机对照试验
养生
置信区间
体质指数
二甲双胍
胰岛素
内分泌学
作者
Zubin Punthakee,Stephanie Hall,Natalia McInnes,Diana Sherifali,Kate Tsiplova,Faith Kirabo,Thomas Ransom,Stewart B. Harris,Heather Lochnan,Ronald J. Sigal,Mahua Ghosh,Tamara Spaic,Hertzel C. Gerstein,the REMIT‐IDegLira Collaborative Group
摘要
An intensive remission-induction intervention including fixed-ratio insulin degludec/liraglutide reduced the risk of type 2 diabetes relapse within 1 year without sustained remission.
科研通智能强力驱动
Strongly Powered by AbleSci AI